Genotropin: Clinical Trials

13 trials of Genotropin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 recruiting, 1 terminated, 1 unknown. 13 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 10, Recruiting 1, Terminated 1, Unknown 1
Phase 22Completed 1, Terminated 1

Follow Genotropin: new trials by email Literature Review of Genotropin trials Research Report on Genotropin

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
Somatrogon, Genotropin - ISS, SGA
Phase 3RecruitingRabin Medical Center2542026-02-012026-04-30
A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
GenSci004, Genotropin - GHD
Phase 3UnknownChangchun GeneScience Pharmaceutical Co., Ltd.1622023-12-012023-09-11
Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
Genotropin, somatrogon - Growth Hormone Deficiency
Phase 3CompletedPfizer872019-02-072021-10-14
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
Somatropin - Traumatic Brain Injury, Fatigue
Phase 3CompletedThe University of Texas Medical Branch, Galveston722018-08-062025-03-05
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
MOD-4023, Genotropin - Growth Hormone Deficiency
Phase 3CompletedOPKO Health, Inc.442017-12-072021-08-12
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
MOD-4023, Somatropin - Pediatric Growth Hormone Deficiency
Phase 3CompletedOPKO Health, Inc.2242016-12-012025-07-20
Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
Eutropin, Genotropin - Prader-Willi Syndrome
Phase 3CompletedLG Life Sciences342014-06-012019-06-27
A Study of Zomacton in Children With Growth Hormone Deficiency
Genotropin, Zomacton - Growth Hormone Deficiency
Phase 3CompletedFerring Pharmaceuticals1652010-01-012012-07-17
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
somatropin [rDNA origin] for injection - Arthritis, Juvenile Rheumatoid, Crohn Disease
Phase 2 / Phase 3TerminatedNationwide Children's Hospital102007-08-012018-04-12
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
Genotropin - Idiopathic Short Stature
Phase 3CompletedPfizer3162006-12-012016-04-05
Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children
Genotropin - Short Stature
Phase 2 / Phase 3CompletedGöteborg University992003-12-012019-04-30
Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
Genotropin - Juvenile Idiopathic Arthritis, Still Disease, Juvenile-Onset
Phase 3CompletedLudwig-Maximilians - University of Munich501996-03-012007-01-11
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
Genotropin - Growth Disorders
Phase 3CompletedPfizer1101990-03-012007-05-03

Conditions studied

Dwarfism, Pituitary (4)  ·  Arthritis, Juvenile (2)  ·  Dwarfism (2)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  COVID-19 (1)  ·  Chronic Disease (1)  ·  Cognitive Dysfunction (1)  ·  Crohn Disease (1)  ·  Failure to Thrive (1)  ·  Fatigue (1)  ·  Growth Disorders (1)  ·  Prader-Willi Syndrome (1)

Sponsors

Pfizer (3)  ·  OPKO Health, Inc. (2)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (1)  ·  Ferring Pharmaceuticals (1)  ·  Göteborg University (1)  ·  LG Life Sciences (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  Nationwide Children's Hospital (1)  ·  Rabin Medical Center (1)  ·  The University of Texas Medical Branch, Galveston (1)

Countries

United States (7)  ·  India (3)  ·  Israel (3)  ·  Bulgaria (2)  ·  Japan (2)  ·  Poland (2)  ·  Russia (2)  ·  South Korea (2)  ·  Ukraine (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belarus (1)  ·  Canada (1)  ·  Colombia (1)

Top investigators

Bradley Miller (1)  ·  Dana S Hardin, MD (1)  ·  Kerstin Albertsson-Wikland, MD, prof (1)  ·  Maria Halldin, MD (1)  ·  Moshe Phillip, Professor (1)  ·  Randall J Urban, MD (1)  ·  Reiko Horikawa, M.D, Ph. D. (1)  ·  Sten Ivarsson, MD, Prof (1)  ·  Susanne M Bechtold, MD (1)  ·  Tony Cruz (1)

Results publications

PMID 11739431, PMID 14571231, PMID 19001519, PMID 30339244, PMID 31511031, PMID 35405011, PMID 37955005, PMID 38053515, PMID 38717038, PMID 38894576, PMID 39906034, PMID 41183961

NIH funding

2008 (1), 2018 (1)